Immune Checkpoint Inhibitors in Lung Cancer and Melanoma
Author:
Publisher
Elsevier BV
Subject
Oncology (nursing)
Reference62 articles.
1. Overall survival in patients with advanced melanoma who received nivolumab versus investigator's choice chemotherapy in CheckMate 037: a randomized, controlled, open-label phase III trial;Larkin;J Clin Oncol,2018
2. Harnessing the immune system in the treatment of melanoma;McGettigan;J Adv Pract Oncol,2018
3. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015
4. PS3 KEYNOTE-024 Update: pembrolizumab vs platinum-based chemotherapy for advanced NSCLC with PD-L1 tumor proportion score ≥50%;Brahmer;J Thorac Oncol,2018
5. Rubin KM. PD-1 inhibitor therapy: consensus statement from the faculty of the Melanoma Nursing Initiative on managing adverse events;McGettigan;J Adv Pract Oncol,2017
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. PLOD3 facilitated T cell activation in the colorectal tumor microenvironment and liver metastasis by the TNF-α/ NF-κB pathway;Journal of Translational Medicine;2024-01-06
2. Patterns of radiological response to tebentafusp in patients with metastatic uveal melanoma;Melanoma Research;2023-12-19
3. Construction and Evaluation of an M2 Macrophage-Related Prognostic Model for Colon Cancer;Applied Biochemistry and Biotechnology;2023-11-21
4. A decade of liver organoids: Advances in disease modeling;Clinical and Molecular Hepatology;2023-07-01
5. Immune-related pulmonary toxicities of checkpoint inhibitors in non-small cell lung cancer: Diagnosis, mechanism, and treatment strategies;Frontiers in Immunology;2023-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3